Cigna Group: Market Overreacts To PBM Risk, Buy The Dip (Rating Upgrade) (NYSE:CI)

Core Viewpoint - Cigna's stock price has experienced a significant decline, dropping nearly 10% from $303.76 in July to $276.5, with a low of below $240 in November before recovering [1] Group 1: Stock Performance - The stock price of Cigna was $303.76 in July when it was rated as a Hold, indicating that risks and rewards were balanced [1] - The price fell to $276.5, marking a nearly 10% decrease, and dipped below $240 in November before bouncing back [1] Group 2: Analyst Perspective - The analysis emphasizes a focus on clarity and discipline in evaluating companies, aiming to provide a straightforward view of what is working and what isn't [1] - The approach is data-driven, prioritizing numerical analysis and the underlying business rather than following market narratives [1]